Targeting the PI3K/AKT pathway overcomes enzalutamide...

  • Main
  • 2020 / 05
  • Targeting the PI3K/AKT pathway overcomes enzalutamide...
Molecular Cancer Therapeutics 2020 / 05

Targeting the PI3K/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptor

Adelaiye-Ogala, Remi, Gryder, Berkley E., Nguyen, Yen Thi Minh, Alilin, Aian Neil, Grayson, Adlai R, Bajwa, Wardah, Jansson, Keith H., Beshiri, Michael L., Agarwal, Supreet, Rodriguez-Nieves, Jose Ant
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-19-0936
Date:
May, 2020
File:
PDF, 17.52 MB
2020
Conversion to is in progress
Conversion to is failed